GH Research
GHRS • NASDAQ • Stock Fundamentals
GH Research is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Velichka Valcheva, with a market cap of $1.6B.
Market Cap$1.6B
Employees49.0
CEOVelichka Valcheva
CountryIreland
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
GH Research FAQ
Common questions about GH Research
GH Research (GHRS) has a market capitalization of $1.6B and trades on NASDAQ.
GH Research has approximately 49 employees.